kentucky semaglutide gi obstruction lawsuit gastrointestinal law firm Dallas-Fort Worth Wegovy Lawyer glp-1 gastric intestinal obstruction law
Description
Verified for purity
For instance, semaglutide users face a relative risk of 2.10 for constipation compared to placebo, while tirzepatide users have an even higher relative risk of 3.36
GLP-1 medications slow digestion and reduce appetite, which can decrease saliva production and thirst signals
She shares the same goal that you do getting you to look and feel your best
There is no established pharmacological mechanism by which semaglutide would directly cause stool discolouration
